Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study to Examine Efficacy and Cytokines Levels After Meibomian Gland Expression (MGX) With and Without Intense Pulsed Light Treatment (IPL)

NCT03194698 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03194698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03194698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study to Examine Efficacy and Cytokines Levels After Meibomian Gland Expression (MGX) With and Without Intense Pulsed Light Treatment (IPL)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
August 17, 2017
Completion date
December 6, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, ocular rosacea